Nephrocare India is a premier renal care institute located in Kolkata, founded and directed by Dr. Pratim Sengupta. The institute provides holistic treatment and support for various renal problems, including chronic kidney disease, genetic kidney disease, glomerular diseases, urological problems, and end-stage renal disease, including dialysis and transplant. Nephrocare is equipped with modern laboratory and diagnostic facilities (Carepath India) and a pharmacy (Caremed India), offering state-of-the-art facilities for comprehensive renal care. The institute also provides affordable daycare surgeries, world-class radiological diagnostic machinery, and a cafeteria serving renal-friendly cuisines. Caremeds pharma, a part of Nephrocare, offers genuine medicines at attractive discounts. The last investment in Nephrocare India was a significant INR80.80M Venture Round investment on 29 December 2023, with the participation of notable investors including Deepak S. Parekh, Bharat Shah, and Dr. Rajendra Agarwal. The institute's all-encompassing approach to kidney-related problems and its recent venture funding make it a promising venture in the Health Care industry, particularly within the context of India's healthcare landscape.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Venture Round | INR80.80M | 3 | Deepak S. Parekh, Bharat Shah +1 | 29 Dec 2023 |
No recent news or press coverage available for Nephrocare India.